These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 35974660)

  • 41. Gluten worsens non-alcoholic fatty liver disease by affecting lipogenesis and fatty acid oxidation in diet-induced obese apolipoprotein E-deficient mice.
    Aguilar EC; Fernandes-Braga W; Santos EA; Leocádio PCL; Dos Santos Aggum Capettini L; Orellano LAA; Campos PP; Lemos VS; Soares FLP; Navia-Pelaez JM; Alvarez-Leite JI
    Mol Cell Biochem; 2024 Jun; 479(6):1335-1347. PubMed ID: 37402020
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Short-term feeding of a ketogenic diet induces more severe hepatic insulin resistance than an obesogenic high-fat diet.
    Grandl G; Straub L; Rudigier C; Arnold M; Wueest S; Konrad D; Wolfrum C
    J Physiol; 2018 Oct; 596(19):4597-4609. PubMed ID: 30089335
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ketogenic essential amino acids modulate lipid synthetic pathways and prevent hepatic steatosis in mice.
    Noguchi Y; Nishikata N; Shikata N; Kimura Y; Aleman JO; Young JD; Koyama N; Kelleher JK; Takahashi M; Stephanopoulos G
    PLoS One; 2010 Aug; 5(8):e12057. PubMed ID: 20706589
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
    Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
    Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diet-induced induction of hepatic serine/threonine kinase STK38 triggers proinflammation and hepatic lipid accumulation.
    Rawat P; Thakur S; Dogra S; Jaswal K; Dehury B; Mondal P
    J Biol Chem; 2023 May; 299(5):104678. PubMed ID: 37028764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fructose as a key player in the development of fatty liver disease.
    Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H
    World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver.
    Hörbelt T; Knebel B; Fahlbusch P; Barbosa D; de Wiza DH; Van de Velde F; Van Nieuwenhove Y; Lapauw B; Thoresen GH; Al-Hasani H; Müller-Wieland D; Ouwens DM; Kotzka J
    Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2671-2684. PubMed ID: 31336149
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides.
    Cinar R; Godlewski G; Liu J; Tam J; Jourdan T; Mukhopadhyay B; Harvey-White J; Kunos G
    Hepatology; 2014 Jan; 59(1):143-53. PubMed ID: 23832510
    [TBL] [Abstract][Full Text] [Related]  

  • 49. WISP1 promotes non-alcoholic fatty liver disease and skeletal muscle insulin resistance via TLR4/JNK signaling.
    Jung TW; Kang C; Goh J; Chae SI; Kim HC; Lee TJ; Abd El-Aty AM; Jeong JH
    J Cell Physiol; 2018 Aug; 233(8):6077-6087. PubMed ID: 29319180
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dietary saturated fatty acid type impacts obesity-induced metabolic dysfunction and plasma lipidomic signatures in mice.
    Žáček P; Bukowski M; Mehus A; Johnson L; Zeng H; Raatz S; Idso JP; Picklo M
    J Nutr Biochem; 2019 Feb; 64():32-44. PubMed ID: 30428423
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Short-term strength training reduces gluconeogenesis and NAFLD in obese mice.
    Pereira RM; Rodrigues KCDC; Anaruma CP; Sant'Ana MR; de Campos TDP; Gaspar RS; Canciglieri RDS; de Melo DG; Mekary RA; da Silva ASR; Cintra DE; Ropelle ER; Pauli JR; de Moura LP
    J Endocrinol; 2019 Apr; 241(1):59-70. PubMed ID: 30878016
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease.
    Kurek K; Piotrowska DM; Wiesiołek-Kurek P; Łukaszuk B; Chabowski A; Górski J; Zendzian-Piotrowska M
    Liver Int; 2014 Aug; 34(7):1074-83. PubMed ID: 24106929
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Yangonin protects against non-alcoholic fatty liver disease through farnesoid X receptor.
    Dong R; Yang X; Wang C; Liu K; Liu Z; Ma X; Sun H; Huo X; Fu T; Meng Q
    Phytomedicine; 2019 Feb; 53():134-142. PubMed ID: 30668392
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antioxidant properties of tea blunt ROS-dependent lipogenesis: beneficial effect on hepatic steatosis in a high fat-high sucrose diet NAFLD obese rat model.
    Braud L; Battault S; Meyer G; Nascimento A; Gaillard S; de Sousa G; Rahmani R; Riva C; Armand M; Maixent JM; Reboul C
    J Nutr Biochem; 2017 Feb; 40():95-104. PubMed ID: 27866076
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carboxylesterase 2a deletion provokes hepatic steatosis and insulin resistance in mice involving impaired diacylglycerol and lysophosphatidylcholine catabolism.
    Chalhoub G; Jamnik A; Pajed L; Kolleritsch S; Hois V; Bagaric A; Prem D; Tilp A; Kolb D; Wolinski H; Taschler U; Züllig T; Rechberger GN; Fuchs C; Trauner M; Schoiswohl G; Haemmerle G
    Mol Metab; 2023 Jun; 72():101725. PubMed ID: 37059417
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modulation of hepatic steatosis by dietary fatty acids.
    Ferramosca A; Zara V
    World J Gastroenterol; 2014 Feb; 20(7):1746-55. PubMed ID: 24587652
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity.
    Cao YN; Yue SS; Wang AY; Xu L; Hu YT; Qiao X; Wu TY; Ye M; Wu YC; Qi R
    J Ethnopharmacol; 2022 Jun; 292():115146. PubMed ID: 35304272
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance.
    Choi CS; Savage DB; Kulkarni A; Yu XX; Liu ZX; Morino K; Kim S; Distefano A; Samuel VT; Neschen S; Zhang D; Wang A; Zhang XM; Kahn M; Cline GW; Pandey SK; Geisler JG; Bhanot S; Monia BP; Shulman GI
    J Biol Chem; 2007 Aug; 282(31):22678-88. PubMed ID: 17526931
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosis.
    Kasumov T; Li L; Li M; Gulshan K; Kirwan JP; Liu X; Previs S; Willard B; Smith JD; McCullough A
    PLoS One; 2015; 10(5):e0126910. PubMed ID: 25993337
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ceramide synthase 6 (CerS6) is upregulated in alcohol-associated liver disease and exhibits sex-based differences in the regulation of energy homeostasis and lipid droplet accumulation.
    Jeon S; Scorletti E; Dempsey J; Buyco D; Lin C; Saiman Y; Bayen S; Harkin J; Martin J; Hooks R; Ogretmen B; Argemi J; Melo L; Bataller R; Carr RM
    Mol Metab; 2023 Dec; 78():101804. PubMed ID: 37714377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.